LETTER
Synthesis of 2-epi-Cinatrin C1 Dimethyl Ester
67
The excellent stereoselectivity of the NaBH4 reduction of In conclusion, the Rh2(OAc)4-catalyzed oxonium ylide
3 encouraged us to synthesize 2-epi-cinatrin C1 in order to formation–[2,3]-sigmatropic rearrangement reaction of α-
prove the utility of our strategy for the synthesis of cina- diazo-β-keto ester 4 derived from D-glucose stereoselec-
trin derivatives (Scheme 5). The chain extension of the al- tively proceeded to give tetrahydrofuran-3-one 3 as a sin-
lyl group using olefin metathesis with Grubbs’ second gle diastereomer in high yield. The resulting 3 was
generation catalyst and 1-undecene gave (E)-alkene 119 converted into 2-epi-cinatrin C1 dimethyl ester 2. As our
that was reduced to an alkyl group to give 12 in 91% yield results have demonstrated the utility of our strategy for the
in two steps. The nucleophilic addition of a vinyl group to construction of the core structure of cinatrin derivatives,
12 by using vinylmagnesium bromide exclusively pro- the stereoselective introduction of the C1 unit at the 2-
duced α-vinyl adduct 13. This addition displayed the same positon from the β-side and the total synthesis of cinatrin
stereoselectivity as that observed in the reduction of 3. C1 and its derivatives are now in progress.
The stereochemistry of 13 was confirmed by the subse-
quent formation of the acetonide of 15. The vinyl group
was next converted to a methoxycarbonyl moiety by the
References
(1) (a) Doyle, M. P.; McKervey, M. A.; Ye, T. In Modern
Catalytic Methods for Organic Synthesis with Diazo
Compounds; John Wiley & Sons: New York, 1998. (b) For
a review, see: Merlic, C. A.; Zechman, A. L. Synthesis 2003,
1137.
(2) Yakura, T.; Muramatsu, W.; Uenishi, J. Chem. Pharm. Bull.
2005, 53, 989.
(3) Yakura, T.; Matsui, K.; Matsuzaka, K.; Yamashita, M.
Heterocycles 2009, 79, 353.
(4) (a) Itazaki, H.; Nagashima, K.; Kawamura, Y.; Matsumoto,
K.; Nakai, H.; Terui, Y. J. Antibiot. 1992, 45, 38. (b) Tanaka,
K.; Itazaki, H.; Yoshida, T. J. Antibiot. 1992, 45, 50.
(5) (a) Evans, D. A.; Trotter, B. W.; Barrow, J. C. Tetrahedron
1997, 53, 8779. (b) Cuzzupe, A. N.; Florio, R. D.; Rizzacasa,
M. A. J. Org. Chem. 2002, 67, 4392. (c) Cuzzupe, A. N.;
Florio, R. D.; White, J. M.; Rizzacasa, M. A. Org. Biomol.
Chem. 2003, 1, 3572.
usual three-step protocol to afford 14. The removal of the
two silyl groups gave triol 15, and the subsequent forma-
tion of the acetonide of the cis-diol produced 16. Oxida-
tion of 16 to lactone 17 was achieved by Taber’s
procedure,10 whereby the treatment of 16 with pyridinium
dichromate (PDC) and acetic anhydride in CH2Cl2–N,N-
dimethylformamide (DMF) under reflux resulted in 17.
The final deprotection of the acetonide to diol was trou-
blesome because the typical acidic conditions were not
suitable for this transformation. However, the deprotec-
tion was achieved by the treatment of 17 with iodine in
methanol11 under reflux to give 2-epi-cinatrin C1 dimethyl
ester 212,13 in 84% yield.
TBSO
O
TBSO
O
(6) Tanabe, G.; Yoshikai, K.; Hatanaka, T.; Yamamoto, M.;
Shao, Y.; Minematsu, T.; Muraoka, O.; Wang, T.; Matsuda,
H.; Yoshikawa, M. Bioorg. Med. Chem. 2007, 15, 3926.
(7) Rhodium(II)-Catalyzed Reaction of α-Diazo-β-keto
Ester 4: To a solution of Rh2(OAc)4 (17 mg, 0.038 mmol) in
CH2Cl2 (40 mL) was added a solution of 4 (618 mg, 1.27
mmol) in CH2Cl2 (24 mL). The resulting solution was
refluxed for 8 h. After concentration of the reaction, the
residue was purified by column chromatography on SiO2
(5% EtOAc in hexane) to give 3 (459 mg, 79%) as a
colorless oil; [α]D26 +12.9 (c = 0.750, CHCl3). IR (neat):
1781, 1753 cm–1. 1H NMR (300 MHz, CDCl3): δ = 0.09 (s,
6 H), 0.11 (s, 3 H), 0.18 (s, 3 H), 0.90 (s, 9 H), 0.91 (s, 9 H),
2.61–2.81 (m, 2 H), 3.72 (s, 3 H), 3.82 (dd, J = 11.8, 3.0 Hz,
1 H), 3.91 (ddd, J = 8.9, 3.0, 2.1 Hz, 1 H), 4.00 (dd, J = 11.8,
2.1 Hz, 1 H), 4.57 (d, J = 8.8 Hz, 1 H), 5.11–5.21 (m, 2 H),
5.67–5.81 (m, 1 H). 13C NMR (100 MHz, CDCl3): δ = –5.5,
–5.4, –5.3, –4.4, 18.2, 18.3, 25.6 (3), 25.8 (3), 38.4, 52.8,
61.3, 72.3, 80.2, 84.8, 120.2, 130.7, 167.6, 208.6. MS: m/z =
459 [M+ + H]. HRMS (EI): m/z calcd for C22H43O6Si2:
459.2598; found: 459.2578.
(8) Spectroscopic data for 10: colorless crystals; mp 86–88 °C
(from 5% EtOAc in hexane); [α]D21 −30.8° (c = 0.5, CHCl3).
IR (neat): 1740, 1531 cm–1. 1H NMR (300 MHz, CDCl3): δ
= −0.04 (s, 3 H), 0.06 (s, 3 H), 0.09 (s, 3 H), 0.10 (s, 3 H),
0.74 (s, 9 H), 0.91 (s, 9 H), 2.74 (dd, J = 14.0, 7.4 Hz, 1 H),
2.89 (dd, J = 13.6, 7.4 Hz, 1 H), 3.70 (dd, J = 11.8, 4.0 Hz, 1
H), 3.73 (s, 3 H), 3.81 (dd, J = 11.3, 3.3 Hz, 1 H), 4.08 (dt, J
= 5.2, 3.3 Hz, 1 H), 4.52 (t, J = 4.9 Hz, 1 H), 5.01–5.06 (m,
1 H), 5.08 (br s, 1 H), 5.64–5.79 (m, 1 H), 5.75 (d, J = 4.9
Hz, 1 H), 8.25 (d, J = 8.8 Hz, 2 H), 8.32 (d, J = 8.8 Hz, 2 H).
13C NMR (100 MHz, CDCl3): δ = −5.53, −5.46, −5.1, −5.0,
17.7, 18.4, 25.5 (3), 25.9 (3), 38.4, 52.4, 62.4, 71.4, 84.9,
86.2, 119.0, 123.7, 130.8, 131.6, 135.2, 160.7, 163.5, 171.7.
2
C12H25
CO2Me
a
b
3
C9H19
O
O
CO2Me
TBSO
TBSO
TBSO
11
12
HO
HO
TBSO
CO2Me
C12H25
C12H25
CO2Me
d–f
c
O
O
CO2Me
TBSO
TBSO
13
14
HO
O
O
O
HO
CO2Me
C12H25
CO2Me
C12H25
g
h
O
CO2Me
CO2Me
HO
HO
HO
15
16
HO
O
O
O
CO2Me
C12H25
CO2Me
C12H25
j
i
O
O
O
CO2Me
17
CO2Me
2
Scheme 5 Reagents and conditions: (a) 1-undecene, Grubbs’ sec-
ond-generation catalyst, CH2Cl2, reflux, 1 h, 96%; (b) 3 atm H2, Pd/C,
EtOH, r.t., 3 h, 95%; (c) vinylmagnesium bromide, THF, –80 °C, 20
min, 85%; (d) O3, Me2S, CH2Cl2–MeOH, –78 °C, 10 min; (e)
NaClO2, NaH2PO4·H2O, t-BuOH–2-methylbut-2-ene–H2O, r.t., 1 h;
(f) excess CH2N2, Et2O, r.t., 15 min, 82% for 3 steps; (g) concd HCl,
MeOH, r.t., 1.5 h, 92%; (h) 2,2-dimethoxypropane, TsOH, 60 °C,
1.5 h, 91%; (i) PDC, Ac2O, CH2Cl2–DMF, reflux, 1.5 h, 71%; (j) I2,
MeOH, reflux, 45 h, 84%.
© Georg Thieme Verlag Stuttgart · New York
Synlett 2013, 24, 65–68